Inhibition of retinoic acid receptor α phosphorylation represses the progression of triple-negative breast cancer via transactivating miR-3074-5p to target DHRS3
Abstract Background Retinoids are promising agents in the treatment of different types of neoplasia including estrogen receptor-positive breast cancers, whereas refractoriness/low sensitivity is observed in triple-negative breast cancer (TNBC) subtype. However, the reason for these diverse retinoid-...
Main Authors: | Siyue Lou, Hang Gao, Huanwu Hong, Zhihui Zhu, Huajun Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-021-01941-7 |
Similar Items
-
MicroRNA-223 Suppresses Osteoblast Differentiation by Inhibiting DHRS3
by: Shijie Zhang, et al.
Published: (2018-05-01) -
Are Mutations in the DHRS9 Gene Causally Linked to Epilepsy? A Case Report
by: Francesco Calì, et al.
Published: (2020-08-01) -
DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma
by: Xiangjian Luo, et al.
Published: (2019-07-01) -
Apoptosis-promoting properties of miR-3074-5p in MC3T3-E1 cells under iron overload conditions
by: Yi Feng, et al.
Published: (2021-08-01) -
Hypermethylation of DHRS3 as a Novel Tumor Suppressor Involved in Tumor Growth and Prognosis in Gastric Cancer
by: Sha Sumei, et al.
Published: (2021-01-01)